Middle east respiratory syndrome: What we learned from the 2015 outbreak in the republic of Korea

Korean Journal of Internal Medicine

Volumn 33, Issue 2, 2018, Pages 233-246

  Oh, Myoung Don ^a   Park, Wan Beom ^a   Park, Sang Won ^a   Choe, Pyoeng Gyun ^a   Bang, Ji Hwan ^a   Song, Kyoung Ho ^a   Kim, Eu Suk ^a   Kim, Hong Bin ^a   Kim, Nam Joong ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Coronavirus; Coronavirus infections; Disease outbreaks; Korea; Middle East respiratory syndrome coronavirus

Indexed keywords

AMIKACIN; CEFTRIAXONE; CORTICOSTEROID; INTERFERON; LOPINAVIR PLUS RITONAVIR; RIBAVIRIN; ANTIVIRUS AGENT;

ACUTE KIDNEY FAILURE; AIRBORNE INFECTION; ANTIBODY RESPONSE; CASE FATALITY RATE; EPIDEMIC; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HOSPITAL MORTALITY; HUMAN; INCUBATION TIME; INFECTION CONTROL; INFECTION PREVENTION; LABORATORY DIAGNOSIS; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; OCCUPATIONAL EXPOSURE; ORGANIZING PNEUMONIA; PNEUMONIA; PROGNOSIS; PUBLIC-PRIVATE PARTNERSHIP; QUARANTINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROCONVERSION; SOUTH KOREA; THORAX RADIOGRAPHY; TRAVEL; VIRAL CONTAMINATION; VIRUS GENOME; VIRUS SHEDDING; VIRUS TRANSMISSION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CORONAVIRUS INFECTION; CROSS INFECTION; FEMALE; MALE; MIDDLE AGED; SEX RATIO; TRANSMISSION; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CORONAVIRUS INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; REPUBLIC OF KOREA; SEX DISTRIBUTION; YOUNG ADULT;

EID: 85043521664     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2018.031     Document Type: Review

References (95)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814-1820.
2. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV)[Internet]. Geneva: World Health Organization, c2018 [cited 2018 Feb 8]. Available from: http://who.int/emergencies/mers-cov/en/.
3. Ministry of Health Kingdom of Saudi Arabia. MERS-CoV daily update [Internet]. Riyadh (SA): Ministry of Health Kingdom of Saudi Arabia, c2014 [cited 2018 Feb 8]. Available from: https://www.moh.gov.sa/en/CCC/PressReleases/Pages/statistics-2018-01-27-001.aspx.
4. Arabi YM, Balkhy HH, Hayden FG, et al. Middle East respiratory syndrome. N Engl J Med 2017;376:584-594.
5. Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018 In Press.
6. Public Health England. Treatment of MERS-CoV: information for clinicians. Clinical decision-making support for treatment of MERS-CoV patients [Internet]. London (UK): Public Health England, 2017 [cited 2018 Feb 8]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/638628/MERS_CoV_guidance:for_clinicians.pdf.
7. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 2015;6:269-278.
8. Oh MD. The Korean Middle East respiratory syndrome coronavirus outbreak and our responsibility to the global scientific community. Infect Chemother 2016;48:145-146.
9. Lee JY, Kim YJ, Chung EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis 2017;17:498.
10. Kim KM, Ki M, Cho SI, et al. Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary's Hospital. Epidemiol Health 2015;37:e2015041.
11. Yang JS, Park S, Kim YJ, et al. Middle East respiratory syndrome in 3 persons, South Korea, 2015. Emerg Infect Dis 2015;21:2084-2087.
12. Park YS, Lee C, Kim KM, et al. The first case of the 2015 Korean Middle East respiratory syndrome outbreak. Epidemiol Health 2015;37:e2015049.
13. FluTrackers. South Korea coronavirus MERS case list: including imported and exported cases. Ministry of Health & WHO confirmed data only: 2015 outbreak [Internet]. Winter Park (FL): FluTrackers, c2018 [cited 2018 Feb 8]. Available from: https://flutrackers.com/forum/forum/novel-coronavirus-ncov-mers-2012-2014/novel-coronavirus-who-chp-wpro-ecdc-oie-fao-moa-reports-and-updates/south-korea-coronavirus/732065-south-korea-coronavirus-mers-case-list-including-imported-and-exported-cases-ministry-of-health-who-confirmed-data-only-2015-outbreak.
14. Korea Broadcasting System Digital News. MERS-CoV infection: current status-interactive and infographics [Internet]. KBS Digital News, c2013 [cited 2018 Feb 8]. Available from: http://dj.kbs.co.kr/resources/2015-06-08/.
15. Lee SS, Wong NS. Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea. Int J Infect Dis 2015;38:65-67.
16. Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect 2017;95:207-213.
17. Ministry of Health and Welfare. The 2015 MERS outbreak in the Republic of Korea: learning from MERS (The White Paper). Seoul (KR): Ministry of Health and Welfare, 2016:473.
18. Xiao S, Li Y, Sung M, Wei J, Yang Z. A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea. Indoor Air 2018;28:51-63.
19. Oh MD, Choe PG, Oh HS, et al. Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015. J Korean Med Sci 2015;30:1701-1705.
20. Cho SY, Kang JM, Ha YE, et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 2016;388:994-1001.
21. Park GE, Ko JH, Peck KR, et al. Control of an outbreak of Middle East respiratory syndrome in a tertiary hospital in Korea. Ann Intern Med 2016;165:87-93.
22. Park SH, Kim YS, Jung Y, et al. Outbreaks of Middle East respiratory syndrome in two hospitals initiated by a single patient in Daejeon, South Korea. Infect Chemother 2016;48:99-107.
23. Park JW, Lee KJ, Lee KH, et al. Hospital outbreaks of Middle East respiratory syndrome, Daejeon, South Korea, 2015. Emerg Infect Dis 2017;23:898-905.
24. Nam HS, Park JW, Ki M, Yeon MY, Kim J, Kim SW. High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea. Int J Infect Dis 2017;58:37-42.
25. Wu J, Yi L, Zou L, Zhong H, et al. Imported case of MERS-CoV infection identified in China, May 2015: detection and lesson learned. Euro Surveill 2015;20:21158.
26. Wang Y, Liu D, Shi W, et al. Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in china: phylo-genetics and coalescence analysis. MBio 2015;6:e01280-15.
27. Kang CK, Song KH, Choe PG, et al. Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea. J Korean Med Sci 2017;32:744-749.
28. Park SH, Kim WJ, Yoo JH, Choi JH. Epidemiologic parameters of the Middle East respiratory syndrome outbreak in Korea, 2015. Infect Chemother 2016;48:108-117.
29. Park HY, Lee EJ, Ryu YW, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill 2015;20:1-6.
30. Chowell G, Abdirizak F, Lee S, et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med 2015;13:210.
31. Chun BC. Understanding and modeling the super-spread-ing events of the Middle East respiratory syndrome outbreak in Korea. Infect Chemother 2016;48:147-149.
32. Ki M. 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol Health 2015;37:e2015033.
33. Nishiura H, Endo A, Saitoh M, et al. Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis. BMJ Open 2016;6:e009936.
34. Virlogeux V, Fang VJ, Park M, Wu JT, Cowling BJ. Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep 2016;6:35839.
35. Zhang XS, Pebody R, Charlett A, et al. Estimating and modelling the transmissibility of Middle East respiratory syndrome coronavirus during the 2015 outbreak in the Republic of Korea. Influenza Other Respir Viruses 2017;11:434-444.
36. Choi S, Jung E, Choi BY, Hur YJ, Ki M. High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi Arabia and South Korea. J Hosp Infect 2017 Sep 25 [Epub]. https://doi.org/10.1016/j.jhin.2017.09.017.
37. Kucharski AJ, Althaus CL. The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission. Euro Surveill 2015;20:14-18.
38. Kim SW, Park JW, Jung HD, et al. Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea. Clin Infect Dis 2017;64:551-557.
39. Kim T, Jung J, Kim SM, et al. Transmission among healthcare worker contacts with a Middle East respiratory syndrome patient in a single Korean centre. Clin Microbiol Infect 2016;22:e11-e13.
40. Kim YJ, Cho YJ, Kim DW, et al. Complete genome sequence of Middle East respiratory syndrome coronavirus KOR/KNIH/002_05_2015, isolated in South Korea. Genome Announc 2015;3:e00787-15.
41. Lu R, Wang Y, Wang W, et al. Complete genome sequence of Middle East Respiratory syndrome coronavirus (MERS-CoV) from the first imported MERS-CoV case in China. Genome Announc 2015;3:e00818-15.
42. Park WB, Kwon NJ, Choe PG, et al. Isolation of Middle East respiratory syndrome coronavirus from a patient of the 2015 Korean outbreak. J Korean Med Sci 2016;31:315-320.
43. Seong MW, Kim SY, Corman VM, et al. Microevolution of outbreak-associated Middle East respiratory syndrome coronavirus, South Korea, 2015. Emerg Infect Dis 2016;22:327-330.
44. Sabir JS, Lam TT, Ahmed MM, et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 2016;351:81-84.
45. Kim JI, Kim YJ, Lemey P, et al. The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination. Sci Rep 2016;6:18825.
46. Kim DW, Kim YJ, Park SH, et al. Variations in spike glycoprotein gene of MERS-CoV, South Korea, 2015. Emerg Infect Dis 2016;22:100-104.
47. Kim Y, Cheon S, Min CK, et al. Spread of mutant Middle East respiratory syndrome coronavirus with reduced affinity to human CD26 during the South Korean outbreak. MBio 2016;7:e00019.
48. Park D, Huh HJ, Kim YJ, et al. Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb Mol Case Stud 2016;2:a001214.
49. Xie Q, Cao Y, Su J, et al. Two deletion variants of Middle East respiratory syndrome coronavirus found in a patient with characteristic symptoms. Arch Virol 2017;162:2445-2449.
50. Oh MD, Park WB, Choe PG, et al. Viral load kinetics of MERS coronavirus infection. N Engl J Med 2016;375:1303-1305.
51. Min CK, Cheon S, Ha NY, et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep 2016;6:25359.
52. Park WB, Perera RA, Choe PG, et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg Infect Dis 2015;21:2186-2189.
53. Ko JH, Muller MA, Seok H, et al. Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity. Diagn Microbiol Infect Dis 2017;89:106-111.
54. Choe PG, Perera RAPM, Park WB, et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis 2017;23:1079-1084.
55. Choi WS, Kang CI, Kim Y, et al. Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea. Infect Chemother 2016;48:118-126.
56. Rhee JY, Hong G, Ryu KM. Clinical implications of 5 cases of Middle East respiratory syndrome coronavirus infection in a South Korean outbreak. Jpn J Infect Dis 2016;69:361-366.
57. Kim ES, Choe PG, Park WB, et al. Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection. J Korean Med Sci 2016;31:1717-1725.
58. Ko JH, Park GE, Lee JY, et al. Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients. J Infect 2016;73:468-475.
59. Cha RH, Joh JS, Jeong I, et al. Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital. J Korean Med Sci 2015;30:1807-1814.
60. Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 2017;13:227-233.
61. Choi WJ, Lee KN, Kang EJ, Lee H. Middle East respiratory syndrome-coronavirus infection: a case report of serial computed tomographic findings in a young male patient. Korean J Radiol 2016;17:166-170.
62. Park GE, Kang CI, Ko JH, et al. Differential cell count and CRP level in blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak. J Korean Med Sci 2017;32:151-154.
63. Lee H, Ki CS, Sung H, et al. Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea. Infect Chemother 2016;48:61-69.
64. Ki CS, Lee H, Sung H, et al. Korean Society for Laboratory Medicine practice guidelines for the molecular diagnosis of Middle East respiratory syndrome during an outbreak in Korea in 2015. Ann Lab Med 2016;36:203-208.
65. Huh HJ, Ko JH, Kim YE, et al. Importance of specimen type and quality in diagnosing Middle East respiratory syndrome. Ann Lab Med 2017;37:81-83.
66. Lee JH, Lee CS, Lee HB. An appropriate lower respiratory tract specimen is essential for diagnosis of Middle East respiratory syndrome (MERS). J Korean Med Sci 2015;30:1207-1208.
67. Kim SH, Ko JH, Park GE, et al. Atypical presentations of MERS-CoV infection in immunocompromised hosts. J Infect Chemother 2017;23:769-773.
68. Chong YP, Song JY, Seo YB, Choi JP, Shin HS; Rapid Response Team. Antiviral treatment guidelines for Middle East respiratory syndrome. Infect Chemother 2015;47:212-222.
69. Hong KH, Choi JP, Hong SH, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax 2018;73:286-289.
70. Majumder MS, Kluberg SA, Mekaru SR, Brownstein JS. Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015. Emerg Infect Dis 2015;21:2088-2090.
71. Mizumoto K, Endo A, Chowell G, Miyamatsu Y, Saitoh M, Nishiura H. Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015. BMC Med 2015;13:228.
72. Kim SY, Park SJ, Cho SY, et al. Viral RNA in blood as indicator of severe outcome in Middle East respiratory syndrome coronavirus infection. Emerg Infect Dis 2016;22:1813-1816.
73. Virlogeux V, Park M, Wu JT, Cowling BJ. Association between severity of MERS-CoV infection and incubation period. Emerg Infect Dis 2016;22:526-528.
74. Jeong SY, Sung SI, Sung JH, et al. MERS-CoV infection in a pregnant woman in Korea. J Korean Med Sci 2017;32:1717-1720.
75. Kim I, Lee JE, Kim KH, Lee S, Lee K, Mok JH. Successful treatment of suspected organizing pneumonia in a patient with Middle East respiratory syndrome coronavirus infection: a case report. J Thorac Dis 2016;8:E1190-E1194.
76. Jeong H, Yim HW, Song YJ, et al. Mental health status of people isolated due to Middle East respiratory syndrome. Epidemiol Health 2016;38:e2016048.
77. Chun S, Chung CR, Ha YE, et al. Possible transfusion-related acute lung injury following convalescent plasma transfusion in a patient with Middle East respiratory syndrome. Ann Lab Med 2016;36:393-395.
78. Kim JY, Song JY, Yoon YK, et al. Middle East respiratory syndrome infection control and prevention guideline for healthcare facilities. Infect Chemother 2015;47:278-302.
79. Moon SY, Son JS, Lee YH, et al. Middle East respiratory syndrome coronavirus transmission in dialysis unit and infection control interventions in Korea. Infect Control Hosp Epidemiol 2016;37:1514-1516.
80. Park HC, Lee YK, Lee SH, et al. Middle East respiratory syndrome clinical practice guideline for hemodialysis facilities. Kidney Res Clin Pract 2017;36:111-116.
81. van Doremalen N, Bushmaker T, Munster VJ. Stability of Middle East respiratory syndrome coronavirus (MERS- CoV) under different environmental conditions. Euro Surveill 2013;18:20590.
82. Bin SY, Heo JY, Song MS, et al. Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea. Clin Infect Dis 2016;62:755-760.
83. Oh MD. Environmental contamination and viral shedding in MERS patients. Clin Infect Dis 2016;62:1615.
84. Song JY, Cheong HJ, Choi MJ, et al. Viral shedding and environmental cleaning in Middle East respiratory syndrome coronavirus infection. Infect Chemother 2015;47:252-255.
85. Kim SH, Chang SY, Sung M, et al. Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards. Clin Infect Dis 2016;63:363-369.
86. Oh MD. Transmissibility of Middle East respiratory syndrome by the airborne route. Clin Infect Dis 2016;63:1143.
87. Majumder MS, Brownstein JS, Finkelstein SN, Larson RC, Bourouiba L. Nosocomial amplification of MERS-coronavirus in South Korea, 2015. Trans R Soc Trop Med Hyg 2017;111:261-269.
88. Nam HS, Yeon MY, Park JW, Hong JY, Son JW. Healthcare worker infected with Middle East Respiratory Syndrome during cardiopulmonary resuscitation in Korea, 2015. Epidemiol Health 2017;39:e2017052.
89. Kim CJ, Choi WS, Jung Y, et al. Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clin Microbiol Infect 2016;22:880-886.
90. Lee JY, Kim G, Lim DG, et al. Seroprevalence of Middle East respiratory syndrome coronavirus among healthcare personnel caring for patients with middle east respiratory syndrome in South Korea. Infect Control Hosp Epidemiol 2016;37:1513-1514.
91. Ko JH, Lee JY, Baek JY, et al. Serologic evaluation of MERS screening strategy for healthcare personnel during a hospital-associated outbreak. Infect Control Hosp Epidemiol 2017;38:234-238.
92. Moon SY, Son JS, Lee YH, et al. Middle East respiratory syndrome coronavirus transmission in dialysis unit and infection control interventions in Korea. Infect Control Hosp Epidemiol 2016;37:1514-1516.
93. World Health Organization. Management of asymptomatic persons who are RT-PCR positive for Middle East respiratory syndrome coronavirus (MERS-CoV): Interim guidance [Internet]. Geneva: World Health Organization, c2018 [cited 2018 Feb 8]. Available from: http://apps.who.int/iris/bitstream/10665/180973/1/WHO_MERS_IPC_15.2_eng. pdf?ua=1&ua=1.
94. Lee J; Rapid Response Team, Kim WJ. Collaborative intervention of Middle East respiratory syndrome: rapid response team. Infect Chemother 2016;48:71-74.
95. Jeon MH, Kim TH. Institutional preparedness to prevent future Middle East respiratory syndrome coronavirus-like outbreaks in Republic of Korea. Infect Chemother 2016;48:75-80.